SR

Shweta Rohit Bakale

Active Director Director DIN 09176237
DIN 09176237 First appointment May 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2021
Shareholding value •••• Premium profile

About Shweta Rohit Bakale

Data last updated:

Shweta Rohit Bakale is a Director at Bakale Medical Private Limited (since 2021). The company operates in Pharma. Bakale Medical Private Limited reported revenue of ₹2.09 Cr (FY 2025).

DIN 09176237
Primary Designation Director
Industry Pharma
First Appointment 17 May 2021
Oldest Company Age 5 yrs
Largest company Bakale Medical Private Limited · ₹2.09 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bakale Medical Private Limited U85100PN2021PTC201062
Director17 May 20212021₹2.09 Cr (FY 2025)Active

Board colleagues of Shweta Rohit Bakale

Directorship timeline

Open interactive timeline →
Bakale Medical Private Limited
Premium access

Shareholding and investment profile for Shweta Rohit Bakale

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shweta Rohit Bakale

Shweta Rohit Bakale currently holds 1 directorship: Bakale Medical Private Limited (Director, since 17 May 2021, revenue ₹2.09 Cr (FY 2025)).

Shweta Rohit Bakale was first appointed on 17 May 2021 as Director at Bakale Medical Private Limited.

The current boards of Shweta Rohit Bakale's companies include Pravin Purud (Bakale Medical Private Limited), Rohit Govind Bakale (Bakale Medical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available